Stay updated on Fasinumab Long-Term Safety in OA Clinical Trial
Sign up to get notified when there's something new on the Fasinumab Long-Term Safety in OA Clinical Trial page.

Latest updates to the Fasinumab Long-Term Safety in OA Clinical Trial page
- Check7 days agoChange DetectedThe page’s revision label was updated from v3.5.4 to v3.5.5, representing a small update to the study details page.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedAdded a new PubMed publication to the Publications section: DiMartino SJ et al. on the prevalence of preexisting articular bone pathology in OA patients screened for fasinumab, published in Osteoarthritis Cartilage (2024). This expands the study's list of published related research.SummaryDifference0.0%

- Check28 days agoChange DetectedA new revision tag v3.5.4 has been added to the page metadata, and the previous revision tag v3.5.3 has been removed.SummaryDifference0.0%

- Check35 days agoChange DetectedPublications section added with a PubMed citation for a phase III fasinumab study. The Sweden location entry was corrected from Malmo to Malmö, Skåne County, Sweden, 211 52.SummaryDifference0.1%

- Check42 days agoChange DetectedA new page revision tag (v3.5.3) was added to the record, replacing the previous tag (v3.5.2), signaling an administrative update to the page history.SummaryDifference0.0%

- Check57 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Fasinumab Long-Term Safety in OA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fasinumab Long-Term Safety in OA Clinical Trial page.